The Board of Directors of BrightGene Bio-Medical Technology Co., Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.18 CNY | +5.94% |
|
+0.92% | +3.37% |
May. 07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
May. 07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.37% | 1.99B | |
+51.74% | 798B | |
+41.51% | 633B | |
-5.01% | 356B | |
+19.15% | 328B | |
+10.42% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+7.70% | 166B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.